CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s diseaseNicolas R. Barthélemy, Suzanne E. Schindler, Tammie L.S. Benzinger et al.|Nature Aging|2023Cited by 150
Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph‐Mathurin, Richard J. Perrin, Clifford R. Jack et al.|Annals of Neurology|2022Cited by 42